These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24655303)
1. Antimicrobial stewardship of β-lactams in intensive care units. Cotta MO; Roberts JA; Tabah A; Lipman J; Vogelaers D; Blot S Expert Rev Anti Infect Ther; 2014 May; 12(5):581-95. PubMed ID: 24655303 [TBL] [Abstract][Full Text] [Related]
2. Impact of CLSI Breakpoint Changes on Microbiology Laboratories and Antimicrobial Stewardship Programs. Heil EL; Johnson JK J Clin Microbiol; 2016 Apr; 54(4):840-4. PubMed ID: 26791363 [TBL] [Abstract][Full Text] [Related]
3. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy. Ramsamy Y; Muckart DJ; Han KS S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954 [TBL] [Abstract][Full Text] [Related]
5. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS; Frei CR J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Stewardship Approaches in the Intensive Care Unit. Doernberg SB; Chambers HF Infect Dis Clin North Am; 2017 Sep; 31(3):513-534. PubMed ID: 28687210 [TBL] [Abstract][Full Text] [Related]
7. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J; BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians. Kallen AJ; Beekmann SE; Limbago B; Lentnek AL; Polgreen PM; Patel J; Srinivasan A Diagn Microbiol Infect Dis; 2011 Nov; 71(3):316-9. PubMed ID: 21899980 [TBL] [Abstract][Full Text] [Related]
9. Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship. George JM; Towne TG; Rodvold KA Pharmacotherapy; 2012 Aug; 32(8):707-21. PubMed ID: 23307519 [TBL] [Abstract][Full Text] [Related]
10. beta-Lactams without a suicide inhibitor. Giamarellou H Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547 [TBL] [Abstract][Full Text] [Related]
11. [New beta-lactamases in enterobacteriaceae. The Danish Society of Clinical Microbiology]. Hansen DS Ugeskr Laeger; 2006 Mar; 168(12):1228. PubMed ID: 16571319 [No Abstract] [Full Text] [Related]
12. Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates. Manageiro V; Ferreira E; Jones-Dias D; Louro D; Pinto M; Diogo J; Caniça M Diagn Microbiol Infect Dis; 2012 Mar; 72(3):272-7. PubMed ID: 22209509 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy. Harada S; Ishii Y; Yamaguchi K Korean J Lab Med; 2008 Dec; 28(6):401-12. PubMed ID: 19127103 [TBL] [Abstract][Full Text] [Related]
14. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases. Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568 [TBL] [Abstract][Full Text] [Related]
15. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492 [TBL] [Abstract][Full Text] [Related]
16. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939 [TBL] [Abstract][Full Text] [Related]